“

I think that, especially for people who are at significant risk for progression, it's important to take Paxlovid, a percentage of those people -- yet to be determined -- are going to have rebound. But in almost all of those people, the rebound is going to be an inconvenience. And that inconvenience, really, is not as important as the potential of avoiding hospitalization or death.